Drug Search Results
More Filters [+]

PAC-113

Alternative Names: pac-113, pac113, pac 113
Latest Update: 2008-06-26
Latest Update Note: Clinical Trial Update

Product Description

P113 is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in human saliva (Sourced from: http://www.pacgenlife.com/node/171)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pacgen
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PAC-113

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Candidiasis, Oral|HIV Seropositivity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PBC002-01

P2

Completed

Candidiasis, Oral|HIV Seropositivity

2008-06-01

Recent News Events

Date

Type

Title